
    
      Nesfatin-1 levels of patients with type 2 diabetes, insulin resistance and obesity will be
      measured. In addition, patients' daily food consumption will be taken and the amount of
      energy they receive will be calculated daily. The relationship between the level of
      nesfatin-1 in the blood and the energy received will be examined.
    
  